Analysis from the Randomized Phase 3 Aspire Trial - Carfilzomib, Lenalidomide, & Dexamethasone V. Lenalidomide & Dexamethasone
Keith Stewart, MD from Mayo Clinic Division of Hematology and Oncology discusses the analysis from the randomized phase 3 Aspire trial and Carfilzomib, Lenalidomide, & Dexamethasone V. Lenalidomide &...
Author: ASHReport
Added: 01/23/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts